Understanding how certain cells in the brain develop to help repair nerve damage in multiple sclerosis.
Transcriptional regulation of oligodendroglial differentiation
This study is looking at how certain cells in the brain that help repair nerve coverings might not work properly in multiple sclerosis, with the hope of finding new ways to help improve myelin repair and support better nerve function for patients.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10984598 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that control the differentiation of oligodendrocyte precursor cells (OPCs), which are crucial for producing myelin, the protective sheath around nerves. By exploring the role of transcription factors and circadian rhythms in OPC behavior, the study aims to uncover why remyelination fails in multiple sclerosis (MS). Patients may benefit from insights that could lead to new therapies aimed at enhancing myelin repair and improving neurological function. The research employs advanced techniques, including CRISPR-based screens, to analyze gene expression and cell behavior in the context of MS.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis who are experiencing symptoms related to nerve damage.
Not a fit: Patients with other neurological disorders unrelated to myelin damage may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance myelin repair in patients with multiple sclerosis, potentially improving their quality of life.
How similar studies have performed: Previous research has shown promising results in understanding the role of transcription factors in neural repair, suggesting that this approach could yield significant insights.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Rojo Capitanio, Daniela — Stanford University
- Study coordinator: Rojo Capitanio, Daniela
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.